国家: 爱尔兰
语言: 英文
来源: HPRA (Health Products Regulatory Authority)
Lactulose
Bristol Laboratories Limited
A06AD; A06AD11
Lactulose
3.335 g/5ml
Oral solution
Product not subject to medical prescription
Osmotically acting laxatives; lactulose
Not marketed
2016-10-28
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT LACTULOSE 3.335 G/5 ML ORAL SOLUTION LACTULOSE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. • You must talk to your doctor if you do not feel better or if you feel worse after several days. WHAT IS IN THIS LEAFLET 1. What this medicine is and what it is used for 2. What you need to know before you take this medicine 3. How to take this medicine 4. Possible side effects Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking this medicine. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking this medicine if you suffer from any medical conditions or illnesses, in particular: • if you suffer from unexplained tummy ache • if you are unable to digest milk sugar (lactose) • if you have diabetes You should not take this medicine if you suffer from: • galactose or fructose intolerance coma). This is also known as a 'hepatic coma'. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE THIS MEDICINE DO NOT TAKE THIS MEDICINE IF: • You are allergic to lactulose or any of the other ingredients of this medicine (listed in section 6) • You have a rare problem called 'galactosaemia' (a severe genetic disorder where you cannot digest galactose) • You have a blockage caused by anything else but normal constipation, digestive perforation or risk of digestive perforation. TAKING OTHER MEDICINES Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines. LACTULOSE WITH FOOD AND DRINK Lactulose ca 阅读完整的文件
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lactulose 3.335 g/5 ml oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5ml of oral solution contains Lactulose 3.335 g. Excipients with known effect: Also contains small amounts of lactose, galactose, fructose, tagatose or epilactose. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral solution Clear, viscous liquid, colourless or pale brownish yellow. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS 1.) For the treatment of constipation. 2.) For the treatment of hepatic encephalopathy (HE): treatment and prevention of hepatic coma or precoma 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The lactulose solution may be administered diluted or undiluted. Each dose may if necessary be taken with water or fruit juices, etc. Each dose of lactulose should be swallowed in one and should not be kept in the mouth for an extended period of time. The posology should be adjusted according to the individual needs of the patient. In case of single daily dose, this should be taken at the same time, e.g. during breakfast. During the therapy with laxatives it is recommended to drink sufficient amounts of fluids (1.5–2 litres, equal to 6-8 glasses) during the day. Dosing in constipation: Lactulose may be given as a single daily dose or in two divided doses. After a few days the starting dosage may be adjusted to the maintenance dose based upon treatment response. Several days (2-3 days) of treatment may be needed before treatment effect occurs. _Lactulose oral solution in bottles:_ STARTING DOSE DAILY MAINTENANCE DOSE DAILY Adults and adolescents 15-45 ml, corresponding to 10-30 g lactulose 15-30 ml, corresponding to 10-20 g lactulose H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ 阅读完整的文件